Ge Healthcare Technologies Stock Cash Per Share
| GEHC Stock | 81.81 0.59 0.72% |
GE HealthCare Technologies fundamentals help investors to digest information that contributes to GE HealthCare's financial success or failures. It also enables traders to predict the movement of GEHC Stock. The fundamental analysis module provides a way to measure GE HealthCare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GE HealthCare stock.
GEHC |
GE HealthCare Technologies Company Cash Per Share Analysis
GE HealthCare's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, GE HealthCare Technologies has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The cash per share for all United States stocks is 100.0% higher than that of the company.
GEHC Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GE HealthCare's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GE HealthCare could also be used in its relative valuation, which is a method of valuing GE HealthCare by comparing valuation metrics of similar companies.GE HealthCare is currently under evaluation in cash per share category among its peers.
GEHC Fundamentals
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.0577 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 44.18 B | ||||
| Shares Outstanding | 457.3 M | ||||
| Shares Owned By Insiders | 0.20 % | ||||
| Shares Owned By Institutions | 88.37 % | ||||
| Number Of Shares Shorted | 9.24 M | ||||
| Price To Book | 4.46 X | ||||
| Price To Sales | 1.92 X | ||||
| Revenue | 19.67 B | ||||
| Gross Profit | 8.21 B | ||||
| EBITDA | 3.67 B | ||||
| Net Income | 2.05 B | ||||
| Total Debt | 1.5 B | ||||
| Book Value Per Share | 18.48 X | ||||
| Cash Flow From Operations | 1.95 B | ||||
| Short Ratio | 3.52 X | ||||
| Earnings Per Share | 4.34 X | ||||
| Price To Earnings To Growth | 2.16 X | ||||
| Target Price | 100.77 | ||||
| Number Of Employees | 53 K | ||||
| Beta | 1.32 | ||||
| Market Capitalization | 37.68 B | ||||
| Total Asset | 33.09 B | ||||
| Retained Earnings | 3.26 B | ||||
| Working Capital | 348 M | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 33.09 B | ||||
| Last Dividend Paid | 0.13 |
About GE HealthCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GE HealthCare Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GE HealthCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GE HealthCare Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock:Check out GE HealthCare Piotroski F Score and GE HealthCare Altman Z Score analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.